Consegna Pharma

Executive Summary

Consegna Pharma Inc. is a privately held specialty pharmaceutical company founded in 2020 and headquartered in Cambridge, Massachusetts. The company focuses on developing best-in-class long-acting injectable (LAI) formulations of known, safe drugs by leveraging a proprietary AI-driven technology platform. This platform accelerates formulation design, targeting therapeutic areas with high patient non-adherence or challenging drug delivery requirements. By reformulating existing drugs into LAIs, Consegna aims to improve patient compliance, reduce dosing frequency, and enhance therapeutic outcomes. With a lean operational model and a clear mission to address unmet needs in adherence and delivery, the company represents an innovative approach to drug reformulation.

Upcoming Catalysts (preview)

• Q3 2026Series A Funding Announcement65% success
• Q1 2027Lead Candidate IND Filing50% success
• Q4 2026Strategic Partnership for AI Platform40% success